TLR4 and Cognitive impairment: GA at two different doses further regulated the over-expression of pro-inflammatory cytokines via toll-like receptor 4 signaling pathway related to neuro-inflammation, resulting in the inflammatory response alleviation and memory loss and cognitive defects risk reduction.